| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,061 |
11,891 |
$1.91M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,951 |
6,798 |
$1.59M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,836 |
3,744 |
$1.10M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,004 |
1,958 |
$232K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,274 |
3,225 |
$158K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,485 |
2,404 |
$130K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
880 |
870 |
$82K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,397 |
2,771 |
$77K |
| 80053 |
Comprehensive metabolic panel |
6,765 |
6,535 |
$64K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
682 |
657 |
$59K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,118 |
6,878 |
$49K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,284 |
1,239 |
$47K |
| 36415 |
Collection of venous blood by venipuncture |
8,059 |
7,557 |
$41K |
| 71045 |
Radiologic examination, chest; single view |
3,255 |
3,187 |
$37K |
| 70450 |
Computed tomography, head or brain; without contrast material |
577 |
571 |
$34K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,271 |
3,147 |
$20K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
177 |
176 |
$15K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
176 |
62 |
$14K |
| 87430 |
|
942 |
938 |
$13K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
433 |
416 |
$13K |
| 81001 |
|
4,350 |
4,145 |
$12K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
125 |
121 |
$11K |
| 86756 |
|
697 |
693 |
$10K |
| 74178 |
|
48 |
48 |
$9K |
| 71046 |
Radiologic examination, chest; 2 views |
539 |
533 |
$8K |
| 80305 |
|
704 |
608 |
$7K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
67 |
66 |
$6K |
| 84484 |
|
504 |
448 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
111 |
109 |
$5K |
| 83880 |
|
149 |
147 |
$5K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
28 |
27 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
162 |
159 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
302 |
296 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
128 |
120 |
$2K |
| 83605 |
|
162 |
155 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
328 |
317 |
$1K |
| 82550 |
|
236 |
219 |
$1K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
19 |
16 |
$999.84 |
| 82553 |
|
83 |
72 |
$952.50 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
13 |
13 |
$911.28 |
| 84703 |
|
105 |
104 |
$726.07 |
| 76813 |
|
14 |
14 |
$723.80 |
| 83735 |
|
111 |
108 |
$653.93 |
| 81025 |
|
86 |
86 |
$562.90 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
81 |
77 |
$450.75 |
| 83690 |
|
58 |
58 |
$348.03 |
| 86850 |
|
15 |
15 |
$338.91 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
51 |
51 |
$320.25 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
13 |
13 |
$278.46 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
12 |
12 |
$259.30 |
| 85610 |
|
67 |
65 |
$250.26 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
29 |
29 |
$224.64 |
| 86696 |
|
14 |
14 |
$223.73 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
104 |
103 |
$195.36 |
| 87040 |
|
18 |
15 |
$194.40 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
101 |
100 |
$189.55 |
| 86762 |
|
14 |
14 |
$166.40 |
| 86695 |
|
14 |
14 |
$164.22 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
169 |
167 |
$158.03 |
| 85730 |
|
28 |
27 |
$153.57 |
| 85027 |
|
25 |
25 |
$145.92 |
| 82728 |
|
14 |
14 |
$145.44 |
| 87186 |
|
14 |
14 |
$130.73 |
| 83550 |
|
14 |
14 |
$108.78 |
| 87077 |
|
13 |
13 |
$107.85 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
28 |
28 |
$94.63 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
12 |
12 |
$88.80 |
| 83540 |
|
14 |
14 |
$80.50 |
| 82247 |
|
17 |
12 |
$75.99 |
| 84100 |
|
14 |
13 |
$59.22 |
| 86592 |
|
14 |
14 |
$53.20 |
| 86901 |
|
16 |
16 |
$39.90 |
| 86900 |
|
16 |
16 |
$37.24 |
| 85007 |
|
12 |
12 |
$35.64 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
14 |
13 |
$8.32 |
| J7510 |
Prednisolone oral, per 5 mg |
70 |
65 |
$1.20 |